by RMIT University The study, conducted by an international team and led by RMIT University’s Professor Christian Doerig, outlines a strategy that could save years of drug discovery research and millions of dollars in drug development by repurposing existing treatments designed for other diseases such as cancer. The approach shows so much promise it has...
Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE By applying the renewal theory in probability to reduce recall bias in initial case reports, scientists have come up with a new estimate for the incubation period of COVID-19....
7 August 2020, 5:59 am EDT By Jamie P. Tech Times Coronavirus has not yet ended. Worse, there is still no official vaccine nor cure to counter its attack on humans. However, China recently found out that another virus revolves around the country, has the same characteristics as the SARS-CoV-2. The virus is called ‘Novel...
Researchers from the Perelman School of Medicine at the University of Pennsylvania have now identified a protein called histone deacetylase 3 (HDAC3) as the orchestrator of the immune system’s inflammation response to infection. By using both specially cultured cells and small animal models, HDAC3 was found to be directly involved in the production of agents...
by University of California – Berkeley California are often cooler than inland areas, granting their populations some protection against West Nile virus. Credit: Public domain photo As climate change brings hotter weather to Southern California, coastal populations from San Diego to Santa Barbara may face an increased risk of contracting West Nile virus and other...
by Johns Hopkins University A cutaway diagram of the ear showing the two regions — the middle ear and mastoid air cells (as indicated by the red arrows) — from where Johns Hopkins researchers recently isolated the SARS-CoV-2 virus (seen at upper right), the cause of COVID-19. Credit: Graphic by M.E. Newman, Johns Hopkins Medicine,...
IMAGE: ATTACK RATE OF COVID-19 PER DIFFERENT SEATS AND CO-TRAVEL TIME ON A HIGH-SPEED TRAIN CREDIT: UNIVERSITY OF SOUTHAMPTON A study by scientists from the University of Southampton has examined the chances of catching COVID-19 in a train carriage carrying an infectious person. Based on high-speed routes in China, researchers from WorldPop found that for...
by Peter Grad , Medical Xpress “This paper made my jaw drop.” “It is just a wacko hypothesis.” “This article isn’t so much a scientific paper as a representation of what a moron thinks a scientific paper is.” “You haven’t seen the stupidest published SARS-CoV-2 take yet [until you read this]. I PROMISE you.” The...
by Sanford Burnham Prebys Medical Discovery Institute Discovery Institute, gestures to experimental assays that test for compounds that may treat COVID-19. Credit: Sanford Burnham Prebys Medical Discovery Institute A Nature study authored by a global team of scientists and led by Sumit Chanda, Ph.D., professor at Sanford Burnham Prebys Medical Discovery Institute, has identified 21...
by Mary L. Martialay, Rensselaer Polytechnic Institute In a test of antiviral effectiveness against the virus that causes COVID-19, an extract from edible seaweeds substantially outperformed remdesivir, the current standard antiviral used to combat the disease. Heparin, a common blood thinner, and a heparin variant stripped of its anticoagulant properties, performed on par with remdesivir...
